All India Institute of Medical Sciences, Bhubaneswar

aiimsbhubaneswar.nic.in

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

54

Active

15

Phase 3

2

Total enrollment

4,155

Pipeline matrix

Showing 12 of 12 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Aripiprazole2
Tofacitinib 5 mg BID and Triamcinolone ointment1
Hyaluronic Acid1
Mitomycin -C1
Dosulepin2
Venlafaxine2
Steroid1
Antibiotic1
Prosman1
Atenolol 25 mg1
Ivabradine 10mg1
RhizomK1

Next readouts

  • 2025-06-30
  • 2025-10-31
  • 2026-05-30
  • 2026-08
  • 2026-10
  • 2027-01-01
  • 2027-04-04
  • 2027-10-30

Top conditions

  • Schizophrenia5
  • Treatment Resistant Schizophrenia3
  • Major Depressive Disorder3
  • Oral Lichen Planus2
  • Perforated Bowel2
  • Post-Op Complication2
  • Emergencies2
  • Non-Alcoholic Fatty Liver Disease2

Frequently asked questions about All India Institute of Medical Sciences, Bhubaneswar

How many clinical trials does All India Institute of Medical Sciences, Bhubaneswar have on ClinicalTrials.gov?
All India Institute of Medical Sciences, Bhubaneswar is listed as the lead sponsor on 54 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
How many of All India Institute of Medical Sciences, Bhubaneswar's trials are in Phase 3?
2 of All India Institute of Medical Sciences, Bhubaneswar's trials are in Phase 3, spread across 12 active drug programs.
What therapeutic areas does All India Institute of Medical Sciences, Bhubaneswar focus on?
All India Institute of Medical Sciences, Bhubaneswar's most-studied conditions on ClinicalTrials.gov are Schizophrenia, Treatment Resistant Schizophrenia, Major Depressive Disorder, Oral Lichen Planus, Perforated Bowel.
When are All India Institute of Medical Sciences, Bhubaneswar's next clinical trial readouts?
All India Institute of Medical Sciences, Bhubaneswar has 8 upcoming primary-completion readouts tracked here; the soonest is “Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.”, expected around 2025-06-30.